New Lawsuits Filed Over Ozempic Side Effects

Many of us have come across advertisements for Ozempic, an FDA-approved injection used to treat type 2 diabetes. However, these injections and others have gained popularity on social media platforms such as Instagram and TikTok for their alleged potential to help with weight loss, even though the FDA does not approve them for that specific purpose.

Novo Nordisk, the manufacturer of Ozempic, has been promoting its weight loss benefits since its initial commercials aired in 2018. However, medical literature has linked the injection to serious complications such as gastroparesis and other severe injuries.

As a result, consumers who have experienced these injuries have started filing lawsuits against Novo Nordisk. The first lawsuit was filed in the U.S. District Court for the Western District of Louisiana in August 2023 and a class action was filed in British Columbia on behalf of all Canadians later that year. The Canadian class action alleges that Novo Nordisk failed to warn them about the potential side effects.

At Beasley Allen, our attorneys are investigating cases where individuals were diagnosed or treated for gallbladder removal, severe or permanent stomach paralysis, gastroparesis, other gastrointestinal injuries, intraoperative pulmonary aspiration, ileus or bowel obstruction, pancreatic cancer, or suicide.

If you became ill after using one of these medications, do not face additional health complications alone. We offer a free case evaluation to determine if you may be eligible for compensation and can guide you through the legal process every step of the way.

Free Case Evaluation

Since 1979, Beasley Allen has been committed to “helping those who need it most.” Our attorneys have helped thousands of clients get the justice they desperately needed and deserved. You pay us nothing if we do not win for you. Contact us today for a free case evaluation.

For Disclaimers, see our Terms of Use.

Free Case Evaluation Full - Updated

"*" indicates required fields

This field is for validation purposes and should be left unchanged.